The COMET (Comparison of Operative versus Monitoring and Endocrine Therapy) trial: a phase III randomised controlled clinical trial for low-risk ductal carcinoma in situ (DCIS) - Hwang, ES; Hyslop, T; Lynch, T (BMJ Open, 2019)